Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Pharmaceutical Segment — Worldwide sales by Year
Pharmaceutical Segment — Worldwide sales ($M) ($M)
Merck Pharmaceutical Segment — Worldwide sales: $58,142M in FY2025, up 1.3% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| PHARMACEUTICAL | 14,349 | 14,760 | 29,109 | 13,638 | 14,050 | 27,688 | 15,611 | 14,843 | 58,142 | 5 | 4 | 5 | 3”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Table 3 / 3a / 3b / 3c & Form 10-Q / 10-K Segment Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Segment — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 58,142 | +1.3% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 57,400 | +7.1% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 53,583 | +3.0% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 52,005 | +21.6% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 42,754 | +16.8% | Form 8-K (tm2227726d1_ex99-1.htm, filed 2022-10-27) ↗ |
| FY2020 | Dec 31, 2020 | 36,610 | -12.3% | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2019 | Dec 31, 2019 | 41,751 | +10.8% | Form 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗ |
| FY2018 | Dec 31, 2018 | 37,689 | +6.5% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | 35,390 | +0.7% | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| FY2016 | Dec 31, 2016 | 35,151 | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Breakdown
What makes up pharmaceutical Segment — Worldwide sales
- Pharmaceutical Sales — United States ($M)34,409 · FY2025
- Pharmaceutical Segment — Total International sales ($M)23,733 · FY2025
- Pharmaceutical Sales — Europe ($M)10,449 · FY2025
- Pharmaceutical Sales — China ($M)1,816 · FY2025
- Pharmaceutical Sales — Japan ($M)2,632 · FY2025
- Pharmaceutical Sales — Asia Pacific (other than China and Japan) ($M)2,323 · FY2025
- Pharmaceutical Sales — Latin America ($M)2,578 · FY2025
- Pharmaceutical Sales — Eastern Europe / Middle East / Africa ($M)1,598 · FY2025
- Pharmaceutical Sales — Canada ($M)547 · FY2025
- Pharmaceutical Sales — Other Countries ($M)1,790 · FY2025
- Pharmaceutical Segment — Worldwide reported growth YoY (%)1.0% · FY2025
- Pharmaceutical Segment — Worldwide constant-currency (ex-exchange) growth YoY (%)1.0% · FY2025
Cite this data
StockData. (2026). Merck Pharmaceutical Segment — Worldwide sales ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-pharma-seg
See every metric in the Merck KPI table. Data updated Oct 26, 2026.